Anti-E. faecalis Therapeutic Antibody

  • Check with publisher
  • Published date: November 20, 2017
    • Shirley, New York, United States

This antibody generated to the E. faecalis antigens can potentially be used in diagnostic assays. http://www.creativebiolabs.net/Anti-E-faecalis-Therapeutic-Antibody-44542.htm

Bella
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • 483 Covers a Broad Gradation of Problems

    483 Covers a Broad Gradation of Problems

    Biomedical Sciences Fremont (California) August 14, 2017 Check with publisher

    Overview: How you respond to the 483 should provide the foundation for any future communication with the FDA about a particular inspection. Understanding how FDA organizes its evaluation of the 483 can facilitate the FDA’s review in your favor as it ...

  • Clinical Trials - Medical Device FDA's Program 2017

    Clinical Trials - Medical Device FDA's Program 2017

    Biomedical Sciences Fremont (California) June 14, 2017 Check with publisher

    Overview: The topic is device clinical trials. This term refers to the use of medical products on/in humans, in order to gain useful knowledge about the product. Why should you Attend: In spite of the long experience device companies have with clinic...

  • Laboratory-Developed Tests - Medical devices 2017

    Laboratory-Developed Tests - Medical devices 2017

    Biomedical Sciences Fremont (California) June 14, 2017 Check with publisher

    Overview: This presentation will review the legal definition of medical device, and how it is applied by FDA to in vitro diagnostic tests. It will review the history of FDA interest in LDTs, and will describe the current situation with respect to Lab...